LEMMON AWAITS GENERIC SUCRALFATE APPROVAL FOLLOWING PREAPPROVAL INSPECTION BY FDA "TWO MONTHS AGO"; FIRM HAS 43 ANDAs PENDING AT AGENCY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".